Amphastar Pharmaceuticals Inc sell BiotechBee
Start price
07.07.24
/
50%
€35.11
Target price
07.07.25
€28.00
Performance (%)
-0.03%
End price
13.07.24
€35.10
Summary
This prediction ended on 13.07.24 with a price of €35.10. The SELL prediction by BiotechBee for Amphastar Pharmaceuticals Inc closed nearly unchanged from the start price. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amphastar Pharmaceuticals Inc | -2.770% | -2.770% | -36.476% |
| iShares Core DAX® | -6.016% | -4.595% | 1.274% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.573% |
| iShares Nikkei 225® | -7.156% | -2.215% | 28.107% |
| iShares S&P 500 | -0.257% | -0.841% | 10.196% |
According to BiotechBee what are the pros and cons of Amphastar Pharmaceuticals Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Amphastar Pharmaceuticals Inc diskutieren
Sell mit Kursziel 28,0